One Stem Cell Lab, Continues to Follow FDA Regulations of Minimally Manipulated Tissue and Explicitly Does NOT Manufacture, Distribute, the Use of Cord Blood (Hematic Stem Cells-HSC) in Any of One Stem Cell Lab's Products.

Press Release (ePRNews.com) - RICHARDSON, Texas - Oct 09, 2018 - One Stem Cell Lab, continues to follow FDA regulations of minimally manipulated tissue and explicitly does NOT manufacture, distribute, the use of cord blood (Hematic Stem Cells-HSC) in any of One Stem Cell Lab’s  Products. One Stem Cell Lab is regulated solely under the authority of section 361 of the PHS Act and the regulations in 21 CFR Part 1271.

In light of recent events, One Stem Cell Lab, a pioneer in the industry, explicitly follows FDA Regulations for minimally manipulated tissue. Our intravenous and sub-cutaneous injections do not contain any cord blood and are strictly mesenchymal stem cells (MSC).

For further inquiries please contact One Stem Cell Lab at:

One Stem Cell Lab, continues to follow FDA regulations of minimally manipulated tissue and explicitly does NOT manufacture, distribute, the use of cord blood

One Stem Cell Lab

1(833)-267-3522

info@onestemcelllab.com

www.onestemcelllab.com

Source : One Stem Cell Lab
Business Info :
One Stem Cell Lab

You may also like this  

DISCLAIMER : If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/services/business mentioned and hereby disclaims any content contained in this press release.

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login